Form 4 for IMDX Insight Molecular Diagnostics Inc.

Accepted 2022-08-19 00:00:00 ET · period of report 2022-08-17 · accession 0001493152-22-023522 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2022-08-19	2022-08-17	IMDX	Arno Andrew	Dir	P - Purchase	$0.9	+15.0K	15.0K	New	+$13.5K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, no par value	2022-08-17	P	A	7,500	$0.9	15,000	I See footnote	—	—	(F1) The price of $0.90 per share represents a weighted average of prices ranging from $0.88 to $0.92 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F2) The shares of common stock are held by JBA Investments LLC. The Reporting Person is the Manager of JBA Investments LLC and in such capacity has the right to vote and dispose of the securities held by such entity.
2	Common	Common Stock, no par value	2022-08-17	P	A	7,500	$0.9	15,000	I See footnote	—	—	(F1) The price of $0.90 per share represents a weighted average of prices ranging from $0.88 to $0.92 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F3) The shares of common stock are held by MJA Investments LLC. The Reporting Person is the Manager of MJA Investments LLC and in such capacity has the right to vote and dispose of the securities held by such entity.